← back to search

Anton Delwig

SiteOne Therapeutics (United States) · US
Area of research
Molecular Biology · Cellular and Molecular Neuroscience
Research interest
Research interests include Ion channel regulation and function, Neuroscience and Neuropharmacology Research, Circadian rhythm and melatonin, and Retinal Development and Disorders.
h-index
11
citations
495
works
27
NIH funding
primary concept
email

Recent publications

Therapeutic safety implications of SARM1 active site inhibitors: subinhibitory concentrations cause neurodegeneration
npj Drug Discovery. 2025cited by 6position: middledoi
Context-Specific Stress Causes Compartmentalized SARM1 Activation and Local Degeneration in Cortical Neurons
Journal of Neuroscience 2024cited by 9position: middledoi
Evaluation of Selective NaV1.7 Inhibitors for the Treatment of Ocular Pain
Investigative Ophthalmology & Visual Science 2018cited by 1position: first
Retinofugal Projections from Melanopsin-Expressing Retinal Ganglion Cells Revealed by Intraocular Injections of Cre-Dependent Virus
PLoS ONE 2016cited by 54position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Samantha A. Green · Scripps Institution of Oceanography2 papers (2024–2025)Flora I. Hinz · Gene Therapy Laboratory2 papers (2024–2025)Casper C. Hoogenraad · Utrecht University2 papers (2024–2025) · 1 papers (2025–2025) · 1 papers (2024–2024) · 1 papers (2024–2024) · 1 papers (2024–2024)Martin Weber · Kantonsspital St. Gallen1 papers (2025–2025)Liling Liu · Sunesis (United States)1 papers (2025–2025) · 1 papers (2025–2025) · 1 papers (2025–2025) · 1 papers (2025–2025) · 1 papers (2025–2025) · 1 papers (2024–2024) · 1 papers (2025–2025)David H. Hackos · Neurological Surgery1 papers (2024–2024)Seong Kwon Hur · Texas A&M University1 papers (2025–2025)J. Du Bois · Palo Alto University1 papers (2018–2018)Brett M. Babin · California Institute of Technology1 papers (2025–2025)David C. Yeomans · Palo Alto University1 papers (2018–2018)